These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 25143071)
61. Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials? Jauw YW; Menke-van der Houven van Oordt CW; Hoekstra OS; Hendrikse NH; Vugts DJ; Zijlstra JM; Huisman MC; van Dongen GA Front Pharmacol; 2016; 7():131. PubMed ID: 27252651 [TBL] [Abstract][Full Text] [Related]
62. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793 [TBL] [Abstract][Full Text] [Related]
63. Exploitation of CD133 for the Targeted Imaging of Lethal Prostate Cancer. Glumac PM; Gallant JP; Shapovalova M; Li Y; Murugan P; Gupta S; Coleman IM; Nelson PS; Dehm SM; LeBeau AM Clin Cancer Res; 2020 Mar; 26(5):1054-1064. PubMed ID: 31732520 [TBL] [Abstract][Full Text] [Related]
65. Radiation Dosimetry Study of [(89)Zr]rituximab Tracer for Clinical Translation of B cell NHL Imaging using Positron Emission Tomography. Natarajan A; Gambhir SS Mol Imaging Biol; 2015 Aug; 17(4):539-47. PubMed ID: 25500766 [TBL] [Abstract][Full Text] [Related]
66. Radioimmunotherapy of prostate cancer in human xenografts using monoclonal antibodies specific to prostate specific membrane antigen (PSMA): studies in nude mice. Vallabhajosula S; Smith-Jones PM; Navarro V; Goldsmith SJ; Bander NH Prostate; 2004 Feb; 58(2):145-55. PubMed ID: 14716739 [TBL] [Abstract][Full Text] [Related]
67. Zr-89 Immuno-PET Targeting Ectopic ATP Synthase Enables In-Vivo Imaging of Tumor Angiogenesis. Park BN; Kim GH; Ko SA; Shin GH; Lee SJ; An YS; Yoon JK Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412537 [TBL] [Abstract][Full Text] [Related]
68. CEACAM5-Targeted Immuno-PET in Androgen Receptor-Negative Prostate Cancer. Imberti C; De Gregorio R; Korsen JA; Hoang TT; Khitrov S; Kalidindi T; Nandakumar S; Park J; Zaidi S; Pillarsetty NVK; Lewis JS J Nucl Med; 2024 Jul; 65(7):1043-1050. PubMed ID: 38782457 [TBL] [Abstract][Full Text] [Related]
71. Comparison between pelvic PSMA-PET/MR and whole-body PSMA-PET/CT for the initial evaluation of prostate cancer: a proof of concept study. Domachevsky L; Bernstine H; Goldberg N; Nidam M; Catalano OA; Groshar D Eur Radiol; 2020 Jan; 30(1):328-336. PubMed ID: 31332559 [TBL] [Abstract][Full Text] [Related]
72. Lesion detection by [ Verhoeff SR; van Es SC; Boon E; van Helden E; Angus L; Elias SG; Oosting SF; Aarntzen EH; Brouwers AH; Kwee TC; Heskamp S; Hoekstra OS; Verheul H; van der Veldt AAM; de Vries EGE; Boerman OC; van der Graaf WTA; Oyen WJG; van Herpen CML Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1931-1939. PubMed ID: 31172212 [TBL] [Abstract][Full Text] [Related]
74. Oligometastases in prostate cancer : Metabolic response in follow-up PSMA-PET-CTs after hypofractionated IGRT. Baumann R; Koncz M; Luetzen U; Krause F; Dunst J Strahlenther Onkol; 2018 Apr; 194(4):318-324. PubMed ID: 29181556 [TBL] [Abstract][Full Text] [Related]
75. Molecular imaging of T cell co-regulator factor B7-H3 with Burvenich IJG; Parakh S; Lee FT; Guo N; Liu Z; Gan HK; Rigopoulos A; O'Keefe GJ; Gong SJ; Goh YW; Tochon-Danguy H; Scott FE; Kotsuma M; Hirotani K; Senaldi G; Scott AM Theranostics; 2018; 8(15):4199-4209. PubMed ID: 30128047 [TBL] [Abstract][Full Text] [Related]
76. Biodistribution and Dosimetry of Intraventricularly Administered Pandit-Taskar N; Zanzonico PB; Kramer K; Grkovski M; Fung EK; Shi W; Zhang Z; Lyashchenko SK; Fung AM; Pentlow KS; Carrasquillo JA; Lewis JS; Larson SM; Cheung NV; Humm JL J Nucl Med; 2019 Dec; 60(12):1794-1801. PubMed ID: 31405921 [TBL] [Abstract][Full Text] [Related]
77. Clinical Translation of a Dual Integrin αvβ3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer, 68Ga-BBN-RGD. Zhang J; Niu G; Lang L; Li F; Fan X; Yan X; Yao S; Yan W; Huo L; Chen L; Li Z; Zhu Z; Chen X J Nucl Med; 2017 Feb; 58(2):228-234. PubMed ID: 27493267 [TBL] [Abstract][Full Text] [Related]